Improving patient-important outcomes in haemodialysis through validation and implementation in registries and pragmatic clinical trials [ 1/1/2021 - 12/31/2025 ]

Research Grant

Brief description Haemodialysis is the most common treatment for kidney failure but is associated with poor survival, high symptom burden and drastically reduced quality of life. Research often does not address these patient-important outcomes, thereby limiting our ability to discover effective interventions. This program aims to improve haemodialysis outcomes that are critically important to patients and clinicians through validation and implementation in clinical practice, registries and clinical trial.

Funding Amount $408,082

Funding Scheme Investigator Grants

Chief Investigator Dr Andrea Viecelli

Notes Emerging Leadership 1